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INTRODUCTION
Breast cancer is the most common form of malignancy
in women and is characterised by hormonal, genetic and
environmental origins.1 Certain forms of breast cancer
constitutively produce substantial quantities of reactive
oxygen species (ROS) such as the superoxide anion rad-
ical, the hydroxyl radical and hydrogen peroxide (H2O2)
that confer a potential advantage in proliferation, migra-
tion and invasion of surrounding tissues through the
egradation of the extracellular matrix and an increase in
cell motility.2–4 Furthermore, the role of ROS in the
spread of breast cancer may not only be limited to their
mutagenic activity that drives carcinoma progression.5
In our previous study, we demonstrated that breast can-
cer also created systemic conditions that increased the
level of H2O2 in circulating cells.
6 Such systemic condi-
tions may also favour survival and further invasion of
breast cancer cells.
Many features of breast cancer are clinically treatable by
chemotherapy and/or external irradiation.7 Administration
of selected chemotherapy agents (includingcyclophos-
phamide and doxorubicin) and ionising radiation results
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To compare the effects of ionising radiation on leukocytes from breast cancer patients and healthy
subjects ex vivo, the level of NF-κB and the antioxidant enzymes manganese-containing superoxide
dismutase (Mn-SOD), copper/zinc-containing superoxide dismutase (CuZn-SOD) and catalase
(CAT) in combination with flow cytometric analysis of CD4+ lymphocytes was performed. The
level of Mn-SOD protein was significantly increased in the breast cancer study group both before
(P < 0.001) and after (P < 0.001) irradiation when compared with healthy subjects. Measurements
in parallel indicated that the level of CAT protein was significantly higher in the breast cancer study
group after irradiation (2 Gy [P < 0.001] and 9 Gy [P < 0.05]) when compared with healthy subjects.
Although the initial number of lymphocytes in the blood of breast cancer patients was not different
from healthy subjects, the percentage of apoptotic CD4+ cells was significantly (P < 0.001) lower
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in free radical and ROS production intended to reduce
the rate of breast cancer cell proliferation.8 Unfort-
unately, a number of the physiological side effects of
these therapies are related to oxidative damage induced
by increased ROS.9,10 We have previously shown that
breast cancer CAF chemotherapy (a combination of
cyclophosphamide, doxorubicin and fluorouracil) failed
to compensate for the increase in H2O2, therefore creat-
ing systemic conditions for the survival and invasion of
breast cancer cells.6 It is, therefore, suggested that the
modulation of the oxidant/antioxidant balance towards a
more reduced state by the systemic administration of
low molecular weight substances such as selenium may
limit invasion of most cancer cells and relieve the side
effects of CAF therapy. For the evaluation of the sys-
temic effect of ROS imposed by either breast cancer or
by anti-cancer and/or antioxidant supplementation ther-
apy, a simple clinical ex vivotest would be convenient.
One possible candidate for such a test system might be a
versatile and rapid assay that has been previously used to
determine the sensitivity to ionising radiation in healthy
individuals based on evaluation of peripheral blood
leukocyte cytotoxicity.11,12 The quantification of apop-
totic CD4+ lymphocytes, the highly ionising radiation-
sensitive subpopulation of peripheral blood leukocytes,
is performed by flow cytometric evaluation of their size,
granularity, antigen immunofluorescence and DNA con-
tent. It was shown to be a highly sensitive biological
‘dosemeter’ capable of detecting exposures as low as
0.05 Gy with discrimination of ± 0.1 Gy.13
In the present study, we performed experiments to
determine if differences in NF-κB, manganese-contain-
ing superoxide dismutase (Mn-SOD), copper/zinc-con-
taining superoxide dismutase (CuZn-SOD) and catalase
(CAT) expression persisted in peripheral blood cells
after primary culture and if the Crompton’s lymphocyte
cytotoxicity assay may be used to evaluate the effects of
a further increase in the level of ROS. We used ionising
radiation as a source of ROS (ionising radiation is
known to generate ~10–6 M of different ROS per 1-Gy
dose while the cumulative intracellular concentration of
ROS in healthy tissues is ~10–8 M14,15).
PATIENTS AND METHODS
Patients
Sixteen women diagnosed with breast cancer (age range,
30–60 years; mean, 49.9 ± 9.7 years) were recruited for
this study prior to receiving any medication. The patients
were clinically categorised as stages III or IV breast can-
cer and locally advanced breast cancer (LABC) patients.
Sixteen women deemed healthy (age range, 30–60 years;
mean, 44.8 ± 8.4 years) were used as control subjects.
Both breast cancer/LABC patients and healthy controls
were fully informed and consented to be volunteers in
our study. The whole study was approved by the
Institution Review Board of the Institute of Oncology
and Radiology of Serbia.
Cell irradiation and flow cytometry analysis
Heparinised whole blood samples were diluted 1:10 in
RPMI 1640 medium with 20% fetal bovine serum before
being divided into three 25-cm2 flasks (5 ml per flask).
One flask was left as a control whereas the other two
were irradiated with 2 Gy and 9 Gy (the gamma ray dose
rate was 20 Gy/h). Thereafter, the flasks were placed in a
culture incubator for 48 h at 37°C in an atmosphere of
5% CO2/95% air. Blood cells (4.5 ml of the suspension)
were pelleted by centrifugation (200 g for 10 min at
room temperature) before being lysed (see below). The
remaining 400 µl of suspension was incubated for 15
min at room temperature in the dark with a monoclonal
anti-CD4 antibody (Becton Dickinson, BD#345768;
CD4-FITC, 10 ml per 200 ml of cell suspension).
Erythrocytes were lysed using FACS lysing solution
(BD#349202). Leukocytes were pelleted, washed with
PBS and resuspended in 0.1 ml of FACS Flow solution
(BD#342003) followed by the addition of 0.05 ml of
RNase (bovine pancreas RNaseA; Serva, Heidelberg,
Germany). Propidium iodide was added (final concen-
tration 1 mg/ml) to stain the cellular DNA.
Multiparameter sample measurements were performed
using a BD FACScalibur flow cytometer to discriminate
the three major types of leukocytes and to gate for nor-
mal and apoptotic lymphocytes allowing data acquisi-
tion.11 The data were processed with BD Lysis II
software.
SDS-PAGE and Western blotting
Cell pellets from whole blood samples (see above) were
lysed using 10 mM Tris-HCl pH 7.4 buffer containing
1% Triton X-100, 0.32 M sucrose, 5 mM MgCl2 and pro-
tease inhibitor cocktail The protein concentration was
determined by the method of Lowry et al.16 Proteins in
aliquots of denatured lysates were separated by SDS-
polyacrylamide gel electrophoresis (SDS-PAGE)17
before being transferred to nitrocellulose membranes.
The membranes were blocked using 10 mM Tris buffer
pH 7.4 containing 150 mM NaCl, 1% BSA and 0.1%
Tween-20. The membranes were separately incubated
overnight (at 4°C) with the following antibodies: rabbit
anti-NF-κB (NF-κB p65 C-20; SC-372; Santa Cruz
Biotechnology, Santa Cruz, CA, USA), rabbit anti-Mn-
SOD and rabbit anti-CuZn-SOD (SOD-101, SOD-102
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Nventa [previously Stressgen Biotechnologies] San
Diego, CA, USA), rabbit anti-CAT (Calbiochem,
Darmstadt, Germany) and rabbit anti-actin (C-11: sc-
1615; Santa Cruz Biotechnology). A secondary goat
anti-rabbit IgG alkaline phosphatase conjugate SAB-301
(Stressgen Biotechnologies) was used for detection pur-
poses. The quantification of specific antigen bands was
achieved by computer image processing. The level of a
specific protein was normalised to the level of actin and
expressed in arbitrary units (AU/mg of total protein)
from four independent Western blots. Statistical analyses
were performed by using two-factor analysis of variance
(ANOVA) according to previously published protocols.18,19
RESULTS
Our study employed the conventional peripheral blood
leukocyte radiosensitivity assay based on DNA and cell-
surface marker assessment of cytotoxicity in order to
monitor and evaluate the constitutive and radiation-
induced level of the redox-sensitive protein NF-κB and
the levels of the antioxidant enzymes Mn-SOD, CuZn-
SOD and CAT in the blood cells of healthy subjects and
breast cancer patients ex vivo.
The number of total lymphocytes, the number of CD4+
lymphocytes and the percentage of apoptotic CD4+ lym-
phocytes in blood samples taken from breast cancer
patients and healthy subjects both before and after irradi-
ation is shown in Figure 1 (A–C, respectively). The
number of total lymphocytes in both study groups was
not different. A significant reduction in the number of
total lymphocytes was observed after 9 Gy irradiation
only in the control group (Fig. 1A and Table 2). After
irradiation, the fraction of CD4+ lymphocytes in blood
samples taken from breast cancer patients was signifi-
cantly higher compared with that in healthy subjects
(Fig. 1B and Table 2). The percentage of apoptotic CD4+
lymphocytes was significantly lower in blood samples
taken from breast cancer patients when compared with
healthy subjects (Fig. 1C and Table 2). In addition, the
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Fig. 1. The number of total lymphocytes (A), the fraction of CD4+
lymphocytes per 104 leukocytes (B), and the percentage of apoptotic CD4+
lymphocytes (C) in the blood of breast cancer patients and healthy subjects
treated with 0, 2 or 9 Gy of ionising radiation (represented as mean ± SD).
White bars, healthy subjects; hatched bars, breast cancer patients. In healthy
subjects, significant differences between 9-Gy irradiated versus non-
irradiated samples were apparent (***P < 0.001 and **P < 0.01). Significant
differences (***P < 0.001 and *P < 0.05) between other measured samples
are indicated by the horizontal links between the columns.
Table 1. Protein expression of NF-κB, Mn-SOD, CuZn-SOD and CAT in the blood cells of healthy subjects and breast cancer
patients treated with 0, 2 or 9 Gy of ionising radiation (represented as mean ± SD)
Group NF-κB level Mn-SOD level CuZn-SOD level CAT level 
(AU/mg) (AU/mg) (AU/mg) (AU/mg)
Control (n = 16) 9.0 ± 4.5 55.1 ± 26.3 41.1 ± 7.1 6.7 ± 3.3
Control + 2 Gy 7.5 ± 4.4 59.6 ± 27.8 43.4 ± 8.9 5.8 ± 2.9
Control + 9 Gy 7.2 ± 3.6 60.5 ± 33.6 43.5 ± 11.0 5.3 ± 3.4
Breast cancer (n = 16) 8.3 ± 4.7 92.3 ± 45.1*** 46.1 ± 8.6 9.1 ± 5.1
Breast cancer + 2 Gy 7.9 ± 4.9 113.7 ± 86.8*** 46.0 ± 5.5 12.2 ±7.3***
Breast cancer + 9 Gy 7.8 ± 5.0 126.8 ± 99.3*** 43.5 ± 7.1 8.1 ± 5.2*
Significant differences (***P < 0.001) between breast cancer samples (non-irradiated and irradiated) and their corresponding
control samples were apparent in the case of Mn-SOD. Significant differences between breast cancer + 2 Gy and control + 2
Gy and between breast cancer + 9 Gy and control + 9 Gy were observed in the case of CAT (***P < 0.001 and *P < 0.05,
respectively).
percentage of apoptotic CD4+ cells significantly
increased in blood samples taken from healthy subjects
after irradiation (Fig. 1C and Table 2).
Western blotting of blood cell extracts revealed that
the level of NF-κB protein was not significantly altered
after either a 2-Gy or 9-Gy dose of irradiation in either of
the two study groups (Fig. 2 and Table 1). The level of
both Mn-SOD and CAT was significantly increased in
blood samples of breast cancer patients both before and
after irradiation when compared with healthy subjects
(Fig. 2, Tables 1 and 2). The level of CuZn-SOD did not
vary between blood samples of the two study groups.
20 Adz̆ic, Niciforovic, Zaric et al.′′ ′ ′
Fig. 2. Western blotting detection of NF-κB (p65), Mn-SOD, CuZn-SOD, CAT and β-actin in total blood cell lysates of breast cancer patients and healthy
subjects treated with 0, 2 or 9 Gy of ionising radiation. Representative blots from repeated experiments are shown.
Table 2. Two-way ANOVA of the measured parameters
Disease (D) Irradiation (I) D x I Error
CuZn-SOD Df 1 2 2 111
MS 187 17.7 60.8 66.3
F 2.82 0.27 0.92
Mn-SOD Df 1 2 2 123
MS 10,010 5370 2991 3613
F 30.5*** 1.49 0.83
CAT Df 1 2 2 109
MS 486 34.2 40.6 22.3
F 21.8*** 1.53 1.82
NF-κB Df 1 2 2 105
MS 2.65 16.8 3.62 20.3
F 0.13 0.83 0.18
LY Df 1 2 2 54
MS 43,495 3,515,262 59,367 438,524
F 0.99 8.02*** 0.14
CD4+ Df 1 2 2 54
MS 3,819,858 767,646 31,688 152,609
F 25.03*** 5.03** 0.208
Non-apoptotic cells Df 1 2 2 50
MS 0.006 0.027 0.017 0.0011
F 6.07* 25.22*** 15.89***
Comparison factors are the presence of disease (D) and the irradiation (I). The analysis for non-apoptotic cells used
logarithmic data values. The presence of disease significantly affected the activities of Mn-SOD and CAT. Irradiation
significantly affected the number of lymphocytes (LY) and the CD4+ population. Df, degrees of freedom; MS, mean square; F,
values. Statistical differences (***P < 0.001, **P < 0.01 and *P < 0.05) refer to variable listed (CuZn-SOD, Mn-SOD, CAT,
NF-κB, LY, CD4+ and non-apoptotic cells) in the respective column (D, I or the combination D x I).
DISCUSSION
The intracellular balance between ROS generation and
ROS elimination, generally termed ‘cellular redox
homeostasis’, requires co-ordination of several reactions
(taking place within different cell compartments) per-
formed by a complex network of pro-oxidant and anti-
oxidant systems.20 The latter consists of non-enzymatic
ROS scavengers and detoxifying enzymes, as well as
various redox-sensitive transcription factors such as NF-
κB, p53 and AP1 that regulate oxidative stress-related
gene expression.21 Failure to limit ROS accumulation
often results in cellular conditions promoting DNA dam-
age, mutations and chromosomal aberrations which fre-
quently leads to cell cycle arrest and cell death.3–5 In
addition, failure may also promote carcinogenesis.22 A
growing body of evidence suggests that some cancer
cells exhibit increased intrinsic ROS stress, due to
increased metabolic activity and mitochondrial malfunc-
tion.23 In some situations, such conditions provide the
cells with a potential advantage for proliferation, migra-
tion and invasion of the surrounding tissues.2–4 Many of
the currently used therapeutic strategies using cytostatic
drugs and/or ionising radiation take advantage of the
increased level of ROS in cancer cells to enhance thera-
peutic efficiency and selectivity.21 The beneficial effects
of these agents on tumour cell killing is also based on
their ability to generate ROS and damage cells beyond
their repair capacity. Both cytostatic drugs and ionising
radiation frequently exhibit profound toxic side effects
leading to healthy tissue damage,21 such as those
observed after breast cancer therapy.6,24,25 Moreover,
they may create systemic pro-oxidant conditions as
described in our previous study.6
In our present study, the level of the redox-sensitive
transcription factor NF-κB in combination with the level
of the antioxidant enzymes Mn-SOD, CuZn-SOD and
CAT may represent a convenient and easily available
biomarker system for evaluating shifts in the redox
potential towards oxidation imposed by the presence of
malignant disease (such as breast cancer). The expres-
sion level of NF-κB was considered as an indicator of
cell activation,26 while Mn-SOD,27 CuZn-SOD and CAT
expression illustrated the ROS detoxification capacity of
blood cells. We assumed that Crompton’s assay would
accurately detect ROS differences between breast cancer
patients and healthy subjects ex vivo, as well as the
response to ROS enhancement by ROS challenge x
vivo. For an ex vivooxidative source, we decided to use
ionising radiation as its dose is precisely controlled. We
selected the doses of 2 Gy and 9 Gy, to be representative
of the 1.8–2 Gy daily clinical doses given during cura-
tive radiotherapy and the 8–10 Gy single dose given in
palliative radiotherapy. They correspond to 2 x 10–6 M
and 9 x 10–6 M cumulative concentrations of various
ROS.14,15 Although the initial number of lymphocytes in
the blood of breast cancer patients was not different from
the number found in the blood isolated from healthy sub-
jects, the CD4+ lymphocyte subpopulation was increased
in the blood from breast cancer patients. An increased
CD4+ subpopulation of lymphocytes has been previously
connected with conditions of inflammation such as those
observed in ATM syndrome and in Fanconi anaemia.28
The fact that the percentage of apoptotic CD4+ cells was
significantly greater both before and after irradiation in
the blood from healthy subjects indicated cell culture-
induced radioresistance of CD4+ cells in the blood of
breast cancer patients. This radioresistance may have
been the consequence of a significantly higher level of
Mn-SOD and CAT.29,30 In addition, radioresistance of
CD4+ lymphocytes in a population deemed healthy is
related to donor age (the apoptotic response decreases
linearly, 3% every 5 years, between 21–73 years of age).
Thus, systemic exposure to endogenous breast cancer-
induced ROS in vivo results in a CD4+ profile character-
istic of that found in a 10–15 year older healthy
population.31
Our results indicated that NF-κB expression (when
analysed 48 h after culture) in peripheral blood cells iso-
lated from breast cancer patients was not different from
that in cells isolated from healthy subjects. However, a
difference in NF-κB expression in peripheral blood cells
isolated from both breast cancer patients and healthy
subjects at the moment of cell seeding has been previ-
ously reported by ourselves.6 The current result indicates
that NF-κB expression was attenuated by ex vivocell
culture conditions. In contrast to NF-κB, Mn-SOD
expression (after 48 h of culture) in the blood cells of
breast cancer patients still remained significantly higher
compared to that in cells from healthy subjects. Elevated
Mn-SOD expression accompanied by increased CAT
expression in breast cancer blood cells may, therefore,
represent a key survival factor, under the cell culture
conditions. Oxidative stress clearly influences cell
growth under culture conditions and this phenomenon
has been recognised previously.32 Our results show dif-
ferential effects of cell culture on lymphocytes isolated
from breast cancer patients and healthy subjects. The
expression pattern of NF-κB, CuZn-SOD, Mn-SOD and
CAT in blood cells from breast cancer patients was not
significantly changed after either 2-Gy or 9-Gy doses of
ionising radiation indicating that cell culture-induced
oxidative stress made the cells more radioresistant.
CONCLUSIONS
The data presented in this current study indicate that
brief culture of peripheral blood cells clearly potentiates
the oxidative stress imposed by a breast cancer tumour.
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Although the pattern of biomarker expression was
slightly altered by ex vivo conditions, the degree of CD4+
lymphocyte apoptosis may illustrate the degree of
acquired systemic resistance to ROS imposed by the
presence of a tumour. In addition, the combined assay
may be used to investigate substitutional regimens, in
other words to titrate out exact concentrations of antiox-
idants until the complete reversal of both biomarker
expression and CD4+ sensitivity to ROS is achieved.
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